No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeEXECUTIVES

Category: EXECUTIVES

The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.

Avation Medical adds Vice President...

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Steve Purtell Appointed ELIQUENT Life Sciences CFO | Responsible for Directing & Executing ELIQUENT’s Finance Activities

In his role as CFO, Steve Purtelll is responsible for directing and executing all of ELIQUENT’s finance activities.

Dr Paloma H Giangrande Appointed CTO At Eleven Therapeutics | A Prominent Figure In Nucleic Acid Therapeutics for Over a Decade

Dr Paloma H Giangrande brings a wealth of experience and has been a prominent figure in nucleic acid therapeutics for over a decade. Her groundbreaking work at the University of Iowa involved pioneering multiple nucleic acid technologies.

Eric Perreault New Kiyatec CEO to Lead Strategic Expansion

Eric Perreault will continue to lead Kiyatec in its mission to revolutionize cancer care by harnessing the power of functional precision medicine with its KIYA-Predict™ and 3D Predict™ platforms. He succeeds Matt Gevaert, PhD, who after more than 15 years as CEO will remain a member of Kiyatec’s Board of Directors.

X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer

“I am so excited about the future of small molecule drug discovery and X-Chem’s role in that future,” said incoming CEO Karen Lackey. “In my first six months at X-Chem, I have seen top-tier science and met many amazingly talented scientists. Together, we can continue to bring incredible innovation to drug discovery, unlocking the biological problems of the future to the benefit of patients.”

Jim Dillon New CEO at BiVACOR | Experienced Device Executive

Jim Dillon is an experienced medical device executive whose career focus in heart failure has included developing cardiovascular therapies to enable native heart recovery, reducing the size of a patient’s myocardial infarction, repairing adult and congenital cardiac defects, and volume management for acutely decompensated congestive heart failure patients.

Curtis Cluff Named Chief Executive Officer of BioPhotas, Inc.

Curtis Cluff will work closely with founding CEO, Patrick Johnson, who will continue as the Executive Chairman of the Board of Directors, while also serving as the Chief Innovation Officer.

Jim Erickson Appointed CFO of Saluda Medical

"I am thrilled to welcome Jim Erickson to Saluda and believe his proven track record across several financial leadership roles and broad medical device industry experience will add significant value to our organization as we continue to build our innovative platform and grow commercial operations for our first indication," said Jim Schuermann, President & CEO of Saluda Medical.  

Sollis Health Announces New Chief Operating Officer, Jia Jia Ye, as the Concierge Medical Provider Expands

Jia Jia Ye has extensive experience in healthcare operations, particularly her achievements in scaling multi-site operations and enhancing customer experience.

TransCure bioServices Strengthens team with C-suite hire and Boosts North American Preclinical Opportunities

Céline Pinault joins TransCure bioServices with a robust background in financial management and strategic planning. Drawing on over 15 years of experience in finance leadership positions at well-established companies including AplusA, 5àsec and IPSOS, Pinault’s focus will be on driving the company’s global growth by acting as a specialist strategic finance officer.

Reports breaking medical device and biotechnololgy news

About
Press Releases
Advertise
Privacy
Cookie Policy

Contact:  561.316.3330

Offices: No. Carolina / New York

© Medical Device News Magazine 2024

By using this website you agree to accept Medical Device News Magazine Privacy Policy